Skip to main content

COVID-19 Topic Center

Expert Insights

Commentary
By Soumya Vishwanath, PharmD, University of Massachusetts Medical School  The next wave of patient care is upon us: digital therapeutics (DTx)–evidence-based, clinically evaluated software products that treat, manage, and prevent diseases.1 The Food and Drug Administration (FDA) estimated that 325…
Commentary
By Douglas L. Jennings, PharmD, FACC, FAHA, FCCP, FHFSA, BCPS  Volume3, Issue 1 “Pour some sugar on me” SGLT2 inhibitors have morphed into somewhat of a pharmacologic panacea over the last half-decade. First, there was the serendipitous discovery of cardio-protective effects in patients with…
Commentary
Atrial fibrillation is a major health care disorder being the most common arrhythmia, is associated with low quality of life, increased risk of morbidity and mortality, and a very high cost burden.1 Advancing age and tobacco smoking, alcohol abuse, obesity, diabetes, myocardial infarction and heart…
Commentary
By Douglas L. Jennings, PharmD, FACC, FAHA, FCCP, FHFSA, BCPS  Volume 2, Issue 4 Recent data shows that despite all efforts from the heart failure community and in spite of contemporary guideline-directed medical therapy, deaths from heart failure (HF) continue to rise. The rates of death remain…
Commentary
By Douglas L. Jennings, PharmD, FACC, FAHA, FCCP, FHFSA, BCPS  Volume 2, Issue 3 Despite optimal medical therapy—which commonly consists of a cocktail of cardioprotective agents such as antiplatelet, statin, and antihypertensive medications—a significant number of patients with coronary artery…
Commentary
By Yvette C Terrie, BS Pharm, RPh, consultant pharmacist It’s over one year later and COVID-19 is still part of all of our lives. Great strides have been made in learning more about the transmission, prevention and treatment of COVID-19. Moreover, many individuals are trying their best to get back…
Video
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means for care access, and how they foresee this new indication…
Interview
By Julie Gould Jeremy Kenter, DO, board-certified Emergency Medicine Physician and chief medical officer of Ally Medical Emergency Rooms, breaks down challenges in emergency medicine, and discusses Ally Medical ER—a system of emergency room facilities that are fully equipped to treat both minor…
Interview
By Julie Gould  Sudeb Dalai, MD, PhD, senior medical director, Adaptive Biotechnologies, discusses a recent T-cell test that was developed to help detect recent or past COVID-19 infection, explains how the test works, and details what this newly developed test means for the world of diagnostics in…
Video
Tom Kraus, vice president of government relations, ASHP, discusses the recent Department of Health and Human Services (HHS) announcement that allows inactive pharmacists along with pharmacy interns to join the vaccinator force—explaining that as the vaccine supply increases, these additional…
Back to Top